May 23, 2017 / 6:41 AM / 2 months ago

BRIEF-Neurovive says to continue Neurostat clinical development

1 Min Read

May 23 (Reuters) - Neurovive Pharmaceutical

* Neurovive to continue Neurostat clinical development after positive outcome in preclinical and clinical TBI studies Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below